Skip to content
Screener

CeriBell, Inc. CBLL Investing Cash Flow

Investing Cash Flow at other companies

IAR
Integra LifeSciencesIART
-$43.28M-99.9%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
-$645K-252%
iRadimed logo
iRadimedIRMD
-$469K+88.0%
Teladoc Health logo
Teladoc HealthTDOC
-$41.59M+30.3%
iRhythm Holdings, Inc. logo
iRhythm Holdings, Inc.IRTC
-$48.64M+51.8%
ICU Medical logo
ICU MedicalICUI
-$20.14M-111%

Other financials

Income statement

See full
Revenue$28.1M+32.5%
Gross profit$25.9M+38.8%
Operating income-$20.0M-33.6%
Net income-$19.3M-41.2%
EPS (diluted)-$0.51-34.2%

Balance sheet

See full
Cash & equivalents$32.7M-18.6%
Total debt$21.9M+1.7%
Total equity$128.3M-25.5%
Total assets$166.3M-19.9%

Cash flow

See full
Operating cash flow-$12.9M-70.8%
CapEx$17.0K-76.1%
Free cash flow-$12.9M-69.4%

Valuation

See full
Market cap$713.7M+50.8%
Enterprise value$702.95M+54.6%
P/S+0.9×

Profitability

See full
Gross margin88.9%+1.1pp
Operating margin-68.6%+1.5pp
Net margin-64.7%+0.9pp
FCF margin-53.7%+4.4pp

Returns & leverage

See full
Return on equity-43.9%
Debt / equity0.2×0.0×
Current ratio9.2×-4.1×

Where this comes from

Reported directly by CeriBell, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The source filing: CeriBell, Inc.’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 4:49 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-217008
Line itemThree months ended March 31, 2026Three months ended March 31, 2025
Purchases of property and equipment(125)(148)
Purchases of marketable securities(26,733)(29,330)
Proceeds from maturities of marketable securities50,000
Net cash provided by (used in) investing activities22,441(29,609)
Cash flows from financing activities
Proceeds related to employee stock plans1,632152
Debt issuance cost(150)
Net cash provided by financing activities1,6322

Item 1. Financial Statements.

FAQ

What is CeriBell, Inc.'s investing cash flow?
CeriBell, Inc. (CBLL) reported investing cash flow of $22.44M in Q1 2026.
How has CeriBell, Inc.'s investing cash flow changed year-over-year?
CeriBell, Inc.'s investing cash flow increased by 175.8% year-over-year, from -$29.61M to $22.44M.
What does investing cash flow mean?
Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Ask your AI about CeriBell, Inc.'s investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude